Search Results - "Ielasi, A"

Defining a new standard for IVUS optimized drug eluting stent implantation: The PRAVIO study by Gerber, R.T., Latib, A., Ielasi, A., Cosgrave, J., Qasim, A., Airoldi, F., Chieffo, A., Montorfano, M., Carlino, M., Michev, I., Tobis, J., Colombo, A.

“…Objectives: Preliminary Investigation to the Angiographic Versus IVUS Optimization Trial is a single center prospective observational intravascular ultrasound…”
Get full text

Inter-ethnic heterogeneity in valvular morphology and aortopathy of a worldwide bicuspid aortic valve cohort referred for TAVR by Barki, M, Lohani, I L, Bhatt, S B, Glauber, M G, Guagliumi, G G, Tespili, M T, Ielasi, A I

“…Abstract Background Bicuspid aortic valve (BAV) represents one of the most common congenital heart disease. BAV stenosis tipycally occurs in younger,…”
Get full text

Peripheral intravascular lithotripsy to facilitate transfemoral TAVR: a multicentric prospective registry by Nardi, G, De Backer, O, Ristalli, F, Meucci, F, Stolcova, M, Wang, X I, Sondergaard, L, Palmerini, T, Bruno, A G, Al Jabri, A G, Ielasi, A G, Berti, S, Saia, F, Di Mario, C

“…Abstract Background The presence of severe calcific atherosclerotic disease at iliac artery level is a contraindication to transfemoral (TF) TAVI procedures,…”
Get full text

The diabetic dilemma: which drug-eluting stent works best? by Ielasi, A, Latib, A, Colombo, A

“…The relationship between diabetes mellitus and coronary artery disease is well established. The percentage of patients participating in clinical trials of…”
Get more information

1966One-year clinical outcomes following bioresorbable vascular scaffold implantation in patients presenting with acute coronary syndromes versus stable coronary artery disease: results from RAI registry by Moscarella, E., Ielasi, A., Varricchio, A., Cortese, B., Loi, B., Steffenino, G.

Get full text

P2801Hard events after orsiro sirolimus-eluting stent (HEROES) in STEMI: a multicenter registry by De Marzo, V, Parisi, A R, Donahue, M, D'Amario, D, Annibali, G, Manganiello, V, Caruso, M, Ielasi, A, Misuraca, L, Altamura, L, Cortese, B, Canepa, M, Porto, I

“…Abstract Background Primary percutaneous coronary intervention (pPCI) using drug-eluting stents (DES) is the treatment of choice for the ST segment elevation…”
Get full text

Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis treated with transcatheter valve replacement: insights from the BEAT international collaborative registry by Ielasi, A, Moscarella, E, Mangieri, A, Tchetche, D, Kim, W, Pagnesi, M, Sinning, J.M, Landes, U, Kornowski, R, De Backer, O, Nickenig, G, De Biase, C, Sondergaard, L, De Marco, F, Colombo, A

“…Abstract Background Transcatheter aortic valve replacement (TAVR) is an established therapy for symptomatic severe aortic stenosis. Bicuspid aortic valves…”
Get full text

P6378A polymer-free biolimus-coated stent for the management of real-world high bleeding risk patients with coronary artery disease by Ielasi, A, D'Ascenzo, F, Di Biasi, M, Latini, R A, Senatore, G, Grigis, G, Maiorana, F, Colombotto, C, Infantino, V, Vizzi, V, Cortese, B, D'Amico, M, Tespili, M

Get full text

P2794Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free biolimus A9-coated stent: insights from the all-comers FREEDOM registry by Gallone, G, D'Ascenzo, F, Di Biasi, M D, Latini, R A, Vicinelli, P, Poli, A, Boccuzzi, G, Gagnor, A, Gaido, L, Cerrato, E, Varbella, F, Rinaldi, M D, Ielasi, A

“…Abstract Background The LEADERS FREE trial established the favourable clinical profile of a new polymer-free biolimus A9-eluting stent (PF-BES) in patients at…”
Get full text

P5531A systematic follow-up strategy after percutaneous coronary intervention based on patient risk profile: the prospective POST-PCI registry by Ferlini, M, Rossini, R, Musumeci, G, Grieco, N, Trabattoni, D, Cornara, S, Cardile, A, Calchera, I, Russo, F, Ielasi, A, Faggiano, P, Castiglioni, B, Lettieri, C, Klersy, C, Oltrona Visconti, L

“…Abstract Background Redundant clinical and non-invasive examinations after percutaneous coronary intervention (PCI) increase the cost of medical care with no…”
Get full text

P2820Contemporary indications, dual antiplatelet therapy strategies and clinical outcomes for a polymer-free biolimus A9-coated stent: the all-comers FREEDOM registry by Gallone, G, D'Ascenzo, F, Di Biasi, M D, Latini, R A, Vicinelli, P, Poli, A, Boccuzzi, G, Gagnor, A, Gaido, L, Cerrato, E, Varbella, F, Rinaldi, M, Ielasi, A

“…Abstract Background The absence of a polymer-coat along with fast drug absorption represent the benchmark counterpart of the favourable clinical profile of a…”
Get full text

2227Perceived or calculated bleeding risk in patients undergoing percutaneous coronary intervention: inside the post-pci prospective registry by Ferlini, M, Musumeci, G, Grieco, N, Rossini, R, Demarchi, A, Cornara, S, Somaschini, A, Colombo, P, Cardile, A, Calchera, I, Marino, M, Ielasi, A, Pedretti, R, Lettieri, C, Oltrona Visconti, L

Get full text

P787Feasibility of overlapped MAGMARIS bioresorbable scaffold implantation in long lesions: results from a multicenter Italian registry by Quadri, G, Cerrato, E, Garro, N, Leoncini, M, Tomassini, F, Mariani, F, Bellucca, S, Buccheri, D, Bernelli, C, Sganzerla, P, Ferrari, F, Rolfo, C, Geraci, S, Ielasi, A, Varbella, F

Get full text

P5350One year clinical outcome of biodegradable polymer sirolimus eluting stent in diabetes mellitus patients: insight from the ULISSE registry by Pivato, C.A., Beneduce, A., Fabbiocchi, F., Falcone, S., Ielasi, A., Pierri, A., Tespilli, M., De Martini, S., Parisi, R., Anzuini, A., Margonato, A., Briguori, C., Bartorelli, A., Colombo, A., Godino, C.

Get full text

Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey by Valgimigli, Marco, Costa, Francesco, Byrne, Robert, Haude, Michael, Baumbach, Andreas, Windecker, Stephan

“…Our aim was to report on a survey initiated by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) concerning opinion on the evidence…”
Get full text

Long-term survival in patients undergoing drug-eluting stent PCI of the unprotected left main coronary artery according to renal function; Milan and New-Tokyo (MITO) registry by Takagi, K., Ielasi, A., Chieffo, A., Naganuma, T., Godino, C., Latib, A., Carino, M., Montorfano, M., Nakamura, S., Colombo, A.

Get full text

Impact of bifurcation technique on long-term clinical outcomes in 976 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents; Milan and new-Tokyo registry by Takagi, K., Ielasi, A., Chieffo, A., Naganuma, T., Godino, C., Latib, A., Carlino, M., Montorfano, M., Nakamura, S., Colombo, A. C.

Get full text

Broken heart syndrome: tako-tsubo cardiomyopathy by Latib, Azeem, Ielasi, Alfonso, Montorfano, Matteo, Colombo, Antonio

“…Coronary angiography for a suspected acute coronary syndrome did not show significant coronary artery disease. A left ventriculogram showed severe systolic…”
Get full text

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes by Panoulas, Vasileios F, Mastoris, Ioannis, Konstantinou, Klio, Tespili, Maurizio, Ielasi, Alfonso

“…Despite the remarkable benefits obtained following the introduction of the first-generation drug-eluting stent (DES), concerns were raised over its long-term…”
Get full text

Malignant ST segment elevation by Ielasi, Alfonso, Latib, Azeem, Okreglicki, Andrzej, Colombo, Antonio

Get full text